Although there were only 4 BC-PDEs with a HER2 score of 3 + , relative to FET treatment alone, there was a significant trend towards higher tumour apoptosis and tumour apoptosis/necrosis dependent on HER2 status (Fig. 6B). Here, ERBB2 is linked to breast cancer.